Youngbo Chemical Co., Ltd. (KRX:014440)
South Korea
· Delayed Price · Currency is KRW 5,000.00
+5.00 (0.10%)
Last updated: Apr 21, 2025
Youngbo Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 117,567 | 90,279 | 82,989 | 76,803 | 107,369 | Upgrade
|
| Revenue Growth (YoY) | 30.23% | 8.78% | 8.05% | -28.47% | -18.16% | Upgrade
|
| Cost of Revenue | 81,703 | 67,588 | 62,832 | 56,796 | 83,412 | Upgrade
|
| Gross Profit | 35,863 | 22,691 | 20,157 | 20,007 | 23,956 | Upgrade
|
| Selling, General & Admin | 13,439 | 12,666 | 11,142 | 12,132 | 16,364 | Upgrade
|
| Research & Development | 1,816 | 1,975 | 1,951 | 1,903 | 1,344 | Upgrade
|
| Other Operating Expenses | 326.63 | 323.5 | 1,118 | 495.64 | 853.51 | Upgrade
|
| Operating Expenses | 16,461 | 15,741 | 15,184 | 15,638 | 19,545 | Upgrade
|
| Operating Income | 19,402 | 6,951 | 4,973 | 4,369 | 4,411 | Upgrade
|
| Interest Expense | -35.01 | -95.42 | -189.81 | -240.06 | -345.23 | Upgrade
|
| Interest & Investment Income | 1,469 | 868.09 | 680.42 | 215.89 | 303.92 | Upgrade
|
| Currency Exchange Gain (Loss) | 966.08 | 98.88 | 103.11 | 600.44 | 97.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -30.75 | -177.02 | -1,341 | -116.31 | -14.23 | Upgrade
|
| EBT Excluding Unusual Items | 21,772 | 7,645 | 4,226 | 4,829 | 4,452 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.42 | 0.86 | 0.25 | 1.52 | 0.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | 52.53 | -182.91 | 3,285 | -775.82 | -12.62 | Upgrade
|
| Asset Writedown | -21 | -468.67 | -16 | -317.73 | -238.86 | Upgrade
|
| Pretax Income | 21,804 | 6,994 | 7,496 | 3,737 | 4,202 | Upgrade
|
| Income Tax Expense | 2,752 | 915.55 | 414.99 | 1,394 | 1,543 | Upgrade
|
| Earnings From Continuing Operations | 19,051 | 6,079 | 7,081 | 2,344 | 2,659 | Upgrade
|
| Earnings From Discontinued Operations | 3,502 | -118.01 | -391.35 | 1,158 | - | Upgrade
|
| Net Income to Company | 22,554 | 5,961 | 6,689 | 3,502 | 2,659 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 183.24 | Upgrade
|
| Net Income | 22,554 | 5,961 | 6,689 | 3,502 | 2,842 | Upgrade
|
| Net Income to Common | 22,554 | 5,961 | 6,689 | 3,502 | 2,842 | Upgrade
|
| Net Income Growth | 278.37% | -10.89% | 91.03% | 23.21% | -44.49% | Upgrade
|
| Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| EPS (Basic) | 1156.60 | 305.68 | 343.04 | 179.58 | 145.75 | Upgrade
|
| EPS (Diluted) | 1156.60 | 305.68 | 343.04 | 179.58 | 145.75 | Upgrade
|
| EPS Growth | 278.37% | -10.89% | 91.03% | 23.21% | -44.49% | Upgrade
|
| Free Cash Flow | 14,107 | 10,818 | -1,628 | 9,501 | 2,764 | Upgrade
|
| Free Cash Flow Per Share | 723.43 | 554.78 | -83.50 | 487.22 | 141.75 | Upgrade
|
| Dividend Per Share | 350.000 | 50.000 | 50.000 | 100.000 | 75.000 | Upgrade
|
| Dividend Growth | 600.00% | - | -50.00% | 33.33% | -25.00% | Upgrade
|
| Gross Margin | 30.50% | 25.14% | 24.29% | 26.05% | 22.31% | Upgrade
|
| Operating Margin | 16.50% | 7.70% | 5.99% | 5.69% | 4.11% | Upgrade
|
| Profit Margin | 19.18% | 6.60% | 8.06% | 4.56% | 2.65% | Upgrade
|
| Free Cash Flow Margin | 12.00% | 11.98% | -1.96% | 12.37% | 2.57% | Upgrade
|
| EBITDA | 28,126 | 15,260 | 13,632 | 13,166 | 13,984 | Upgrade
|
| EBITDA Margin | 23.92% | 16.90% | 16.43% | 17.14% | 13.03% | Upgrade
|
| D&A For EBITDA | 8,723 | 8,310 | 8,658 | 8,796 | 9,574 | Upgrade
|
| EBIT | 19,402 | 6,951 | 4,973 | 4,369 | 4,411 | Upgrade
|
| EBIT Margin | 16.50% | 7.70% | 5.99% | 5.69% | 4.11% | Upgrade
|
| Effective Tax Rate | 12.62% | 13.09% | 5.54% | 37.29% | 36.72% | Upgrade
|
| Advertising Expenses | 118.35 | 69.87 | 50.48 | 26.96 | 44.27 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.